Skip to main content
Clinical Trials/NCT05597787
NCT05597787
Completed
Not Applicable

Implementing Stigma Reduction Tools Via a Popular Teletraining Platform to Reduce Clinician Stigma and Disparities in HIV Testing, Prevention, and Linkage to Care in Malaysia

University of Delaware1 site in 1 country78 target enrollmentStarted: July 26, 2022Last updated:
ConditionsHiv

Overview

Phase
Not Applicable
Status
Completed
Enrollment
78
Locations
1
Primary Endpoint
Acceptability of Intervention

Overview

Brief Summary

Key populations at risk of HIV (including men who have sex with men, people who inject drugs, transgender women, and female sex workers) are more likely to be infected with HIV but less likely than members of the general population to know of their HIV status, receive HIV prevention counseling, or be linked to HIV care services. Clinician stigma towards these groups remains a potent and persistent driver of these HIV disparities in many places of the world. The investigators propose to incorporate evidence-based stigma reduction tools into a popular teletraining platform for clinicians and pilot test the resulting intervention (Project ECHO® for HIV Prevention and Stigma Reduction) with clinicians in Malaysia, a context wherein clinician stigma and HIV disparities are substantial.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Screening
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • practicing general practitioner or family medicine specialist in Malaysia

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Acceptability of Intervention

Time Frame: Month 9 Assessment

Measured with Acceptability of Intervention Measure. Theoretical or possible range of scores is 1-5, and actual range was 3.50-5. Higher scores indicate greater acceptability.

Feasibility of Intervention

Time Frame: Month 9 Assessment

Measured with Feasibility of Intervention Measure. Theoretical or possible range of scores is 1-5, and actual range was 3.25-5. Higher scores indicate greater feasibility.

Stigma Reduction: Prejudice

Time Frame: Month 9 Assessment

Measured with Feelings Thermometers. Positive/Negative affect is measured on 0-100 point scale, with higher scores indicating more prejudice.

Stigma Reduction: Stereotypes

Time Frame: Month 9 Assessment

Measured with subscale of Multidimensional HIV-Related Stigma Scale. Theoretical or possible range of scores is 1-5, and actual range was 1-3.44. Higher scores indicate greater stereotypes.

Stigma Reduction: Discrimination

Time Frame: Month 9 Assessment

Measured with subscale of Multidimensional HIV-Related Stigma Scale. Theoretical or possible range of scores is 1-5, and actual range was 1-5. Higher scores indicate greater discrimination.

Secondary Outcomes

  • HIV Prevention Procedures: PrEP Prescriptions(Cumulative over 9 month intervention)
  • HIV Prevention Procedures: HIV Testing(Cumulative over 9 month intervention)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials